Germany's Bayer to buy U.S. gene therapy specialist AskBio
BERLIN (AP) -- German health care company Bayer said Monday it is buying Asklepios BioPharmaceutical, a U.S.-based firm specializing in gene therapy, in a deal worth up to $4 billi…
BERLIN (AP) -- German health care company Bayer said Monday it is buying Asklepios BioPharmaceutical, a U.S.-based firm specializing in gene therapy, in a deal worth up to $4 billi…